Dashboard
Discussions
Watchlists
Collections
Tools
More
Events
SIGN UP
SIGN IN
ENTITY
Ocumension Therapeutics (1477 HK)
Watchlist
28
Analysis
Health Care
•
China
Ocumension Therapeutics operates as a pharmaceutical company. The Company focuses on identifying, developing, and commercializing ophthalmic therapies. Ocumension Therapeutics serves customers in the United States and China.
more
Watchlist
Filings
Presentations
Events
Refresh
Exchange Announcement •
25 Apr 2024 17:14
2023 Environmental, Social And Governance Report
Attachment
Exchange Announcement •
25 Apr 2024 17:05
2023 Annual Report
Attachment
Exchange Announcement •
15 Apr 2024 12:07
Voluntary Announcement Primary Endpoints Achieved In The Phase Iii Clinical Trial Of Ot-502 In China
Attachment
Exchange Announcement •
08 Apr 2024 12:00
Voluntary Announcement Completion Of The Phase Iii Clinical Trial Of Ot-702 In China
Attachment
Exchange Announcement •
22 Mar 2024 06:07
(I) Proposed Amendments To The 2021 Share Option Scheme; And (Ii) Proposed Amendments To The 2021 Share Award Scheme
Attachment
Copyright © 2022 Smartkarma Innovations Pte Ltd. All Rights Reserved. v3.32.0
x